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INTRODUCTION
Orofacial clefts are among the most common congeni-
tal malformations of the craniofacial region,1–4 which in-
clude cleft palate only (CP) and cleft lip with or without 
palate (CL/P). Their estimated incidence worldwide is 
about 1 in 1,500–2,000 births for CP and 1 in 700–1,000 
births for CL/P, showing a considerable sex, ethnic, 
and geographic variation.1–3,5,6 For instance, the highest 
 incidence rates for CL/P were reported in Native Ameri-
cans and Asians (China, Japan), and the lowest in Africans 
and Southern Europeans. On the other hand, incidence 
rates for CP seem similar in Europeans, Africans, Native 
Americans, and Asians.3,5–7
Although orofacial clefts most commonly appear as 
isolated conditions, with a generally favorable outcome 
for the patients, it has long been known that they may 
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be frequently associated with other congenital malforma-
tions.8–11 In these cases, the outcome depends primarily 
on the presence and type of associated malformations.12 
However, the proportions of patients with orofacial clefts 
with additional abnormalities varies greatly between stud-
ies, from 1.5% to 64.2%.8–11,13–22 Also, there is no consensus 
on the type of malformations that are most commonly as-
sociated with orofacial clefts.8,10,14,21,22
The interplay of different environmental and genetic 
risk factors has been proposed as an underlying mecha-
nism for orofacial clefts. However, a single major risk 
factor for these congenital malformations has not been 
identified yet, suggesting a more complex etiology than 
the oligogenic model originally proposed.23–27 Moreover, 
consanguinity and a positive family history for orofacial 
clefts also play a role. Those whose parents have a close de-
gree consanguinity and those with a positive family history 
for clefts are subject to higher risks for congenital mal-
formations.25,28,29 Hence, the identification of specific co-
occurring congenital malformations with orofacial clefts 
is important for improving the definition of the etiology 
of this pathology.1,27,30
A combination of epidemiological and clinical ap-
proaches may enhance our understanding of the causes 
and pathogenesis of congenital malformations with im-
plications for the prevention, diagnosis, prognosis, treat-
ment, and counseling as well in the development of 
public health policies. Portugal has several advantages for 
epidemiological studies on orofacial clefts and associated 
congenital malformations. Indeed, it has a relatively ho-
mogenous population, and the treatment is centralized 
in few centers. According to the European Network for 
the Epidemiological Surveillance of Congenital Anoma-
lies (EUROCAT) report, the prevalence of cleft lip with 
or without cleft palate was 7.8 per 10,000 births between 
1980 and 2015 in Southern Portugal.31 Approximately half 
of the patients in this country is or has been at some point 
referred to our cleft lip and palate tertiary care center. 
Therefore, the aim of this study was to assess the preva-
lence and type of associated congenital malformations in 
patients with orofacial clefts who attended our tertiary re-
ferral center in Portugal.
PATIENTS AND METHODS
Study Design
This was a retrospective study carried out at the 
Clefts Unit of the Paediatric Surgery Department at 
Dona Estefânia Hospital - Central Lisbon Hospital Cen-
tre in Lisbon, Portugal. This unit comprises a tertiary 
referral center for the multidisciplinary care of orofacial 
clefts patients in Southern Portugal and the Portuguese 
Islands being the largest in the country. It also receives 
some patients referred from the Portuguese-speaking 
African countries.
Data were collected retrospectively from the medical 
records on all consecutive pediatric patients with orofacial 
clefts, who had at least 1 appointment at the Clefts Unit 
between January 1, 1981, and December 31, 2012.
Patients
Eligible study participants were children (< 18 years 
old) with typical orofacial clefts, ie, CP, cleft lip only (CL), 
and cleft lip and palate (CLP). Orofacial clefts were de-
fined as failures in developing embryonic facial and pala-
tal processes to either completely merge or fuse, which 
results in a predictable series of postnatal deformities. 
Patients were excluded if they had atypical clefts, includ-
ing median, transverse, oblique, and other Tessier types 
of orofacial clefts32 or those whose clinical files did not 
explicitly refer to the presence or absence of associated 
malformations.
Data Collection and Variables
Data were collected from the Cleft Patient Data Sheet, 
usually completed by the physician in the first appoint-
ment by direct interview of the patient or parents and by 
physical examination. Data were also collected from all 
available patients’ medical records (electronic and pa-
per), including prenatal consultation, maternity, neonatal 
unit, outpatient clinic, pediatrics, and pediatric surgery 
files.
Variables under study included the following: date of 
birth, sex, follow-up period, occurrence and laterality of 
the orofacial cleft, associated malformations and respec-
tive molecular diagnosis, family history of orofacial clefts, 
consanguinity between the parents, and prenatal ultra-
sound diagnosis.
Orofacial clefts were described according to Tessier’s 
anatomical classification.32 Their occurrence was catego-
rized as unilateral or bilateral, and complete, incomplete, 
or microform (eg, submucous cleft palate). Cases of oro-
facial clefts were categorized as: without associated mal-
formations, whenever no other congenital abnormalities 
were identified; or with associated malformations, whether 
1 or more congenital abnormalities, unrelated to orofacial 
clefts, were also present. Dental anomalies were excluded 
from this study as associated malformations because most 
of these anomalies are closely related to orofacial clefts.
Cases of orofacial clefts with associated malformations 
were further divided into 4 categories according to their 
etiology: recognized causes, such as chromosomal syn-
dromes (ie, involving clinically significant structural and/
or numerical chromosomal abnormalities), monogenic 
syndromes (ie, related to a single gene), or sequence 
(ie, occurrence of associated anomalies due to a single 
known structural defect), or multiple congenital anoma-
lies (MCAs) of unknown origin. For this study, MCA cases 
were defined as cases with 2 or more structural malforma-
tions (other than the cleft) that could not be explained 
by an underlying syndrome or sequence. The MCA were 
grouped according to the organ system or the anatomic 
region primarily affected.
Each case of orofacial cleft was referred to a consulta-
tion with a geneticist, and the following diagnostic genetic 
tests were performed as appropriate: until 2009, karyotype 
and fluorescence in situ hybridization for the 22q11.2 
region; from 2009, karyotype and multiplex ligation-
dependent probe amplification for the main microdele-
tion/microduplication syndromes, including the 22q11.2 
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region; from 2011, comparative genomic hybridization 
array; and gene-targeted sequencing, as the molecular 
causes for specific monogenic syndromes have been iden-
tified.
Statistical Methods
The collected data were analyzed using the SPSS 
software (version 20.0). Continuous variables were sum-
marized by mean and minimum-maximum. Categorical 
variables were expressed as number and percentage of 
cases in each group (ie, with and without associated mal-
formations) and compared using the Chi-square test or 
Fisher’s exact test, as appropriate. Due to the study design, 
no sample calculation was performed. The statistical sig-
nificance was concluded at the 5% level.
RESULTS
A total of 1,059 patients with orofacial clefts has had at 
least 1 appointment at the tertiary referral center during 
the study period of 31 years. After applying the eligibility 
criteria, 8 subjects were excluded because they had atypi-
cal clefts, and 350 subjects were excluded because they 
had incomplete medical records (not referring explicitly 
to the presence or absence of associated malformations). 
Only the data of the remaining 701 patients were included 
in our analysis. Of those patients, 393 (56.1%) were males 
and 308 (43.9%) were females. Patients were followed up 
until a mean age of 15 years old (minimum 1 year and 2 
months; maximum 33 years).
The prevalence and characteristics of the orofacial 
clefts and associated malformations are shown in Tables 1 
and 2. Overall, the most frequent orofacial cleft was CLP, 
recorded in 287 (40.9%) patients, followed by CP and 
CL, recorded in 249 (35.5%) and 165 (23.5%) patients, 
respectively.
In the 452 children with CL/P, 50.0% (n = 226) had 
left-sided cleft, 25.9% (n = 117) had right-sided cleft, and 
24.1% (n = 109) had bilateral cleft. About 17.3% (n = 78) 
of the children with CL/P had a family history of clefting, 
compared with 15.7% (n = 39) of the 249 children with 
CP. In addition, a prenatal ultrasound diagnosis of cleft 
was obtained in 24.0% of our study population, compris-
ing mostly cases with CL/P (Table 1).
As shown in Table 1, the prevalence of orofacial clefts 
without associated malformations was 482 (68.8%), 
whereas 219 (31.2%) cases were found to have an associ-
ated malformation that required follow-up or treatment. 
Moreover, associated malformations were more frequent 
in children who had CP (in 43.4% of those) than in chil-
dren with CLP (27.5%) or CL (19.4%). Of the 219 chil-
dren with associated malformations, 108 (49.3%) had CP, 
79 (36.1%) had CLP, and 32 (14.6%) had CL (Table 2).
Regarding gender, the group without associated malfor-
mations had 280 males (58.1%) and 202 females (41.9%), 
whereas the group with associated malformations had 105 
males (47.9%) and 114 females (52.1%) (Table 2).
As shown in Table 2, family history of clefting was 
present in 13.9% of the children without associated mal-
formations and in 22.8% of the children with associated 
malformations. Cases with associated malformations had a 
statistically significant lower proportion of prenatal ultra-
sound diagnosis when comparing with the group without 
associated malformations (13.2% versus 18.7%; P < 0.001). 
Finally, parental consanguinity was present in 1.2% of the 
children without associated malformations and in 2.3% of 
children with associated malformations (Table 2).
Table 1. Prevalence and Characteristics of Orofacial Clefts in the Study Population
 Total (n = 701, 100%) CLP (n = 287, 40.9%) CL (n = 165, 23.5%) CP (n = 249, 35.5%)
Laterality, n (%)*     
  Left 226 (50.0) 126 (43.9) 100 (60.6) —
  Right 117 (25.9) 67 (23.3) 50 (30.3) —
  Bilateral 109 (24.1) 94 (32.8) 15 (9.1) —
  Total, n 452 287 165 —
Occurrence, n (%)     
  Complete 490 (69.9) 248 (86.4) 101 (61.2) 141 (56.6)
  Incomplete 211 (30.1) 39 (13.6) 64 (38.8) 108 (43.4)
  Total, n 701 287 165 249
Family history of clefting, n (%)†     
  Yes 117 (24.6) 53 (27.0) 25 (24.3) 39 (22.2)
  No 358 (75.4) 143 (73.0) 78 (75.7) 137 (77.8)
  Total, n 475 196 103 176
Prenatal ultrasound diagnosis, n (%)†     
  Yes 119 (24.0) 80 (39.0) 37 (35.2) 2 (1.1)
  No 377 (76.0) 125 (61.0) 68 (64.8) 184 (98.9)
  Total, n 496 205 105 186
Associated malformations, n (%)     
  Without 482 (68.8) 208 (72.5) 133 (80.6) 141 (56.6)
  With 219 (31.2) 79 (27.5) 32 (19.4) 108 (43.4)
  Total, n 701 287 165 249
Etiology of associated malformations, n (%)     
  Chromosomal syndromes 12 (5.5) 4 (5.1) 0 (0.0) 8 (7.4)
  Monogenic syndromes 18 (8.2) 5 (6.3) 3 (9.4) 10 (9.3)
  Sequence 43 (19.6) 0 (0.0) 0 (0.0) 43 (39.8)
  MCA of unknown causes 146 (66.7) 70 (88.6) 29 (90.6) 47 (43.5)
  Total, n 219 79 32 108
*Considering that cleft palate does not exhibit laterality.
†There were cases in which these variables were not documented in the medical record.
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In both groups of patients, isolated cleft or with associ-
ated malformations, the left side was the most affected. 
However, the group with associated malformations had 
a significantly lower proportion of left side involvement 
(19.6% versus 23.9%) and a higher proportion of right 
side (13.2% versus 11.0%) and bilateral involvement 
(15.5% versus 8.7%), compared with the group without 
associated malformations (P < 0.001).
Regarding the etiology of the associated malforma-
tions, 146 (66.7%) patients had MCA of unknown ori-
gin and 73 (33.3%) patients had recognized conditions. 
Among these, 12 patients (16.4%) had identified chro-
mosomal syndromes, 18 patients (24.7%) had monogenic 
syndromes, and 43 patients (58.9%) had sequences. The 
most frequent chromosomal anomaly was the 22q11.2 de-
letion syndrome, also known as the velocardiofacial or Di-
George syndrome, occurring in 8 CP patients, followed by 
trisomy 13, trisomy 21, 21q deletion, and Klinefelter syn-
drome, in 1 patient each. The most frequently identified 
monogenic syndrome was the Van der Woude syndrome 
(n = 6), followed by Treacher-Collins syndrome (n = 5), 
Goldenhar syndrome (n = 2), orofacial digital syndrome 
type 1 (n = 2), Apert syndrome (n = 1), Gorlin syndrome 
(n = 1), and Kabuki syndrome (n = 1). Finally, the Pierre 
Robin sequence was identified in 43 patients.
Among the 219 patients with associated malforma-
tions, 90 cases (41.1%) had 1 unrelated associated malfor-
mation, whereas 2 associated malformations were found 
in 62 cases (28.3%), and 3 or more associated malforma-
tions were recorded in 67 cases (30.6%).
The number of individuals with a certain organ sys-
tem affected among those with associated malformations 
is shown in Figure 1. Head and neck anomalies were 
the most frequent associated malformations, in 60.3% 
(n = 132) of the patients with associated malformations, 
and among them, eye and ear were the most affected or-
gans. Cardiovascular malformations were the second most 
common anomalies, accounting for recorded malforma-
tions in 28.3% (n = 62) of the patients with associated 
malformations, of which atrial and ventricular septal de-
fects, followed by patent ductus arteriosus, were the most 
prevalent. Musculoskeletal anomalies were the third most 
common malformations, occurring in 26.0% (n = 57) of 
patients, and among them, most were cases of polydactyly 
and limb reductions. In 11.4% (n = 25) of patients, uro-
logic anomalies were also found, being cryptorchidism the 
most common. In 9.6% (n = 21) of the associated malfor-
mations cases, malformations of the digestive system and 
abdominal wall occurred, mostly inguinal and umbilical 
Table 2. Prevalence and Characteristics of Associated 
Malformations in Children with Orofacial Clefts
 
Associated 
 Malformations
P
Without  
(n = 482)
With  
(n = 219)
Gender, n (%)    
  Male 280 (58.1) 105 (47.9)  
  Female 202 (41.9) 114 (52.1) 0.182
Orofacial cleft, n (%)    
  CP 141 (29.3) 108 (49.3)  
  CL 133 (27.6) 32 (14.6)  
  CLP 208 (43.2) 79 (36.1) < 0.001
Laterality, n (%)    
  Left 115 (23.9) 43 (19.6)  
  Right 53 (11.0) 29 (13.2)  
  Bilateral 42 (8.7) 34 (15.5) < 0.001
Family history of clefting 67 (13.9) 50 (22.8) 0.384
Prenatal ultrasound diagnosis 90 (18.7) 29 (13.2) < 0.001
Parental consanguinity 6 (1.2) 5 (2.3) 0.765
Etiology    
  Chromosomal syndromes  12 (5.5)  
  Monogenic syndromes  18 (8.2)  
  Sequence  43 (19.6)  
  MCA of unknown origin  146 (66.7)  
Fig. 1. number of patients with associated malformations by organ system.
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hernias. Finally, malformations of the central nervous sys-
tem appeared in 6.4% (n = 14) of the associated malfor-
mations, of which the majority were reduction deformities 
of the brain.
DISCUSSION
We investigated the prevalence and type of associ-
ated congenital malformations in 701 children with CP 
and CL/P who attended a tertiary referral center during 
a 31-year period. These patients represented most of the 
cases of orofacial clefts born in Southern Portugal and the 
Portuguese Islands between 1981 and 2012. During this 
period, the overall incidence of clefts was around 5.5 per 
10,000 total births in Southern Portugal, according to the 
literature.8 In our study, we found a higher prevalence of 
orofacial clefts in males, which is in agreement with pub-
lished data,1–3,15,33 with a 1.3:1 ratio of affected boys to girls.
A prenatal diagnosis of orofacial cleft was obtained in 
only 24.6% of the study sample, and most of these cases 
correspond to CL/P. In fact, not all the subjects had an 
ultrasound performed, particularly the older ones, as rou-
tine obstetric ultrasound examinations were implemented 
in Portugal in the early 90s. In addition, although the di-
agnostic accuracy of ultrasound examinations has been 
improving over the past years, routine screening for the 
palate is technically more difficult than for the lip and 
is not included in most centers’ protocols.34 Therefore, 
prospective parents should be advised that palatal involve-
ment might be underdiagnosed prenatally.
The frequency of associated congenital malformations 
in children with orofacial clefts was 31.2%, which was 
slightly above the 25.5% and 27.5% previously reported 
by 2 Portuguese studies,14,35 but in agreement with the in-
ternational literature that reports a range from 1.5% to 
64.2%.8,10,11,13,16–22,36–42 This wide variation might be in part 
attributed to the fact that most studies do not report all 
infants born within a certain geographical area, but only 
those referred to a specific unit (frequently tertiary). An-
other possible explanation for this variation is the lack of 
agreement on what should be regarded as a congenital 
defect. In our study, we have included abnormalities that 
could lead to function impairment and, in this sense, re-
quire either continual medical follow-up or treatment.
Similar to the results of our study, previous studies in-
dicated that the orofacial cleft type most frequently asso-
ciated with other malformations was CP.1,8,10,11,13,14,16–22,37–42 
Moreover, we found a significantly higher proportion of 
bilateral involvement in the cases with associated malfor-
mations than in the cases without associated malforma-
tions, in agreement with several studies suggesting that 
more extensive clefts are associated with a higher risk of 
occurrence of other congenital malformations.8–10
In our study, most associated MCA were recorded in 
the head and neck region, accounting for 60.3% of the 
patients with malformations. The second most common 
MCA associated with orofacial clefts were those affecting 
the cardiovascular system, followed by the musculoskel-
etal, the urologic, the digestive, and the central nervous 
systems. From embryological studies, we know that the 
development of facial structures is intimately related and 
interdependent with the development of other structures, 
and we also know that several components may be affected 
by the same etiopathogenic factors in pathological con-
ditions. Also, failure in the adequate development of 1 
anatomic structure may compromise the normal develop-
ment of several dependent ones, as well illustrated by the 
Pierre Robin sequence.43 Thus, associated malformations 
in children with orofacial clefts may involve several ana-
tomic systems, even in areas far from the cleft. Indeed, in 
agreement with our study, the head and neck region, the 
musculoskeletal, cardiovascular, and central nervous sys-
tems are the most cited in the literature. However, there 
are divergent reports regarding which system and which 
congenital malformation is exactly the most common in 
orofacial cleft infants.8–11,13,14,16,18,19,21,39
Once again, different results between studies may be 
due to different sampling methods, how long after birth 
the orofacial clefts cases were examined, differences in 
case definition and inclusion/exclusion criteria, or dif-
ferences between the populations analyzed, which could 
themselves have different incidences of clefts and other 
congenital malformations. For instance, our long follow-
up period (until patients were 15 years old on average) 
may have increased the proportion of minor or non–life-
threatening conditions over serious life-threatening ones, 
which lead to death early in life. We believe that this may 
be responsible for the relatively low proportion of the re-
corded central nervous system malformations in our study. 
In addition, more recent studies may be influenced by the 
fact that several formerly regarded MCA of unknown ori-
gin are now recognized as part of a specific syndrome, se-
quence or chromosomic abnormality. On the other hand, 
we have been increasing our ability to diagnose morpho-
logic anomalies with the development of more accurate 
imaging, genetic and molecular tests.
Potential limitations of this study arise from its retro-
spective observational nature, as our analysis was based 
on the available medical records over a long period of 
31 years, which might have led to variations in case inves-
tigation, genetic diagnostic procedures, and complete-
ness of reporting. Orofacial cleft patients were excluded 
from this study due to missing data on the presence or 
absence of associated malformations. Nevertheless, we 
found a significant homogeneity among registries and 
most patients had a complete Cleft Patient Data Sheet 
with all the variables under study. Another limitation 
might be the study setting, which was hospital-based. 
However, clefting is a condition that requires hospital 
treatment, and therefore, we considered that our study 
population was representative of the Portuguese orofa-
cial cleft patients.
The main strengths of this study include a well-defined 
geographical area (South of Portugal and the Islands), a 
large sample size (n = 701), a long follow-up period, the 
classification into without associated malformations, chro-
mosomic syndromes, monogenic syndromes, sequences 
or MCA of unknown origin, and the examinations by a 
clinical geneticist of the orofacial clefts cases with associ-
ated malformations.
PRS Global Open • 2018
6
CONCLUSIONS
This study provides a basis for research of the etiol-
ogy of orofacial clefts. The presence and nature of differ-
ent synchronous malformations might indicate different 
mechanisms of abnormal prenatal development. Identifi-
cation of smaller subgroups or clusters may be important 
in etiological studies to elucidate the environmental and 
genetic risk factors and the interaction between them.
The overall prevalence of associated malformations 
(nearly 1 in 3 infants) emphasizes the need for a more 
comprehensive evaluation of children with orofacial clefts. 
An early screening routine for other congenital malfor-
mations, particularly those of the head and neck, cardio-
vascular, skeletal, and central nervous systems, should be 
considered in all orofacial clefts patients, especially when 
considering lip surgery within the first days of life, as many 
severe defects may not be diagnosed during the neonatal 
period by clinical examination alone. Genetic counseling 
might be also valuable, particularly in the orofacial cleft 
cases with associated malformations. Strict cooperation be-
tween cleft team members is essential to comprehensively 
cover all aspects of the management of the patient with 
orofacial clefts.
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